Skandinaviska Enskilda Banken (SEB)
NVAX icon

Skandinaviska Enskilda Banken (SEB)’s Novavax NVAX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-575
Closed -$30K – 991
2022
Q2 		$30K Sell
575
-10,571
-95% -$548K ﹤0.01% 978
2022
Q1 		$821K Buy
11,146
+475
+4% +$42.4K ﹤0.01% 777
2021
Q4 		$1.65M Sell
10,671
-13,386
-56% -$2.3M 0.01% 689
2021
Q3 		$4.99M Sell
24,057
-142
-0.6% -$31.3K 0.03% 417
2021
Q2 		$5.14M Buy
24,199
+24,049
+16,033% +$4.41M 0.03% 416
2021
Q1 		$27K Hold
150
– – ﹤0.01% 1086
2020
Q4 		$17K Hold
150
– – ﹤0.01% 1105
2020
Q3 		$16K Sell
150
-600
-80% -$73.1K ﹤0.01% 993
2020
Q2 		$63K Hold
750
– – ﹤0.01% 984
2020
Q1 		$10K Buy
+750
New +$6.35K ﹤0.01% 903

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s NVAX Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Novavax (NVAX) in Q3 2022, closing a stake of 575 shares — an estimated $30K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in NVAX in Q1 2020 and held it in 10 quarters. The position peaked at $5.14M in Q2 2021. 254 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 575 Novavax shares in Q3 2022, an estimated $30K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Novavax in Q1 2020 and held it in 10 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Novavax position peaked at $5.14M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.